Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roblin

Showing results (651-660 of 756) with videos related to

Pageof 76
Sort By:
Cancer Causes & Control : CCC|December 2, 2017
Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosisSharon Hensley Alford, George Divine, Chun Chao, et al.
Annals of Medicine|September 20, 2025
Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter studyYessar Hussain, Saurabh Malhotra, Brett W Sperry, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2013
Drug safety data mining with a tree-based scan statisticMartin Kulldorff, Inna Dashevsky, Taliser R Avery, et al.
Medical Care|March 14, 2023
Factor Analysis in Distinguishing Coronavirus Disease 2019 From Other Influenza-like Illness Using a Validated Patient-Reported Outcome Instrument FLU-PRO Plus: A Prospective Real-world Cohort StudyElla A Chrenka, Douglas W Roblin, Jennifer C Gander, et al.
Therapeutic Advances in Gastroenterology|October 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysisMarc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, et al.
International Journal of Molecular Sciences|April 3, 2021
The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human HealthClarisse Roblin, Steve Chiumento, Cédric Jacqueline, et al.
JAMA Dermatology|June 30, 2018
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical TrialMarina Danilenko, Elaine Stamp, Deborah D Stocken, et al.
JACS Au|September 1, 2021
Nanocatalysts for High Selectivity Enyne Cyclization: Oxidative Surface Reorganization of Gold Sub-2-nm Nanoparticle NetworksHoussein O Nasrallah, Yuanyuan Min, Emmanuel Lerayer, et al.
Annals of Internal Medicine|July 11, 2018
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort StudyDarios Getahun, Rebecca Nash, W Dana Flanders, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel diseaseM Seirafi, B de Vroey, A Amiot, et al.
Pageof 76

Showing results (651-660 of 756) with videos related to

Sort By:
Pageof 76
Cancer Causes & Control : CCC|December 2, 2017
Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosisSharon Hensley Alford, George Divine, Chun Chao, et al.
Annals of Medicine|September 20, 2025
Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter studyYessar Hussain, Saurabh Malhotra, Brett W Sperry, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2013
Drug safety data mining with a tree-based scan statisticMartin Kulldorff, Inna Dashevsky, Taliser R Avery, et al.
Medical Care|March 14, 2023
Factor Analysis in Distinguishing Coronavirus Disease 2019 From Other Influenza-like Illness Using a Validated Patient-Reported Outcome Instrument FLU-PRO Plus: A Prospective Real-world Cohort StudyElla A Chrenka, Douglas W Roblin, Jennifer C Gander, et al.
Therapeutic Advances in Gastroenterology|October 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysisMarc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, et al.
International Journal of Molecular Sciences|April 3, 2021
The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human HealthClarisse Roblin, Steve Chiumento, Cédric Jacqueline, et al.
JAMA Dermatology|June 30, 2018
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical TrialMarina Danilenko, Elaine Stamp, Deborah D Stocken, et al.
JACS Au|September 1, 2021
Nanocatalysts for High Selectivity Enyne Cyclization: Oxidative Surface Reorganization of Gold Sub-2-nm Nanoparticle NetworksHoussein O Nasrallah, Yuanyuan Min, Emmanuel Lerayer, et al.
Annals of Internal Medicine|July 11, 2018
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort StudyDarios Getahun, Rebecca Nash, W Dana Flanders, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel diseaseM Seirafi, B de Vroey, A Amiot, et al.
Pageof 76